🚨 Thrilled to share our latest featured review with @tamaraisermann, @cjder23, and C. Sers: "KRAS Inhibitors: Resistance Drivers and Combinatorial Strategies" now #OpenAccess in @TrendsCancer! 🔬
https://t.co/xEKTffVzOK
Please read it and don’t forget to cite, cite, cite! 😉
An #OpenAccess review on current status of KRAS inhibitors, resistance drivers & potential combinations from @derlabunc@cjder23@papkephd & colleagues @DKFZ@ChariteBerlin in @trendscancer
As always very informative illustrations:
A: Frequency of KRAS Allelic alterations across various cancers
B: Current portfolio of KRAS inhibitors separated by allele specific & agnostic compounds
C: Common mechanisms of genomic & non genomic resistance
D: Potential combinations that are being trialed in preclinical setting & in the clinic.
May was amazing! First poster presentation on my PhD findings at the 18th International p53 workshop at @WeizmannScience, then presenting at the @sfb1321 young scientist symposium of the International conference of the pancreatic Cancer research centres. #CancerResearch#PhD
It's been amazing few days, actually being able to attend a conference in person! Thanks @sfb1321 for organising all of this! #PancreaticCancer#research#kfo5002
Absolutely delighted to finally see it published. All the hard work, long hours and tears have paid off! Couldn't have done it without my amazing colleagues. #colorectalcancer#p53#HSF1#CancerResearch
https://t.co/4NbOsW9ggV
@RLSCameron @dais_stoner@madrozdz@KerstinThol@AreebaSpeaks Also signed! I don't see why people should have to pay for the application, tuition is enough the way it is. They shouldn't discourage young clever and keen students from applying.
@guijacquemet @aboakademi Hey,
Congratulations on opening your lab. I couldn't find your email address to get in contact but I'm very interested in your research and a PhD